BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 14716439)

  • 1. Topical 3% diclofenac in 2.5% hyaluronan gel for the treatment of actinic keratoses.
    Rivers JK
    Skin Therapy Lett; 2004 Jan; 9(1):1-3. PubMed ID: 14716439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses.
    Rivers JK; McLean DI
    Arch Dermatol; 1997 Oct; 133(10):1239-42. PubMed ID: 9382562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does progression from actinic keratosis and Bowen's disease end with treatment: diclofenac 3% gel, an old drug in a new environment?
    Patel MJ; Stockfleth E
    Br J Dermatol; 2007 May; 156 Suppl 3():53-6. PubMed ID: 17488408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of multiple actinic keratoses with topical diclofenac 3% gel in organ transplant recipients: a series of six cases.
    Ulrich C; Hackethal M; Ulrich M; Howorka A; Forschner T; Sterry W; Stockfleth E
    Br J Dermatol; 2007 May; 156 Suppl 3():40-2. PubMed ID: 17488405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze).
    Nelson C; Rigel D; Smith S; Swanson N; Wolf J
    J Drugs Dermatol; 2004; 3(4):401-7. PubMed ID: 15303784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.
    Ulrich C; Johannsen A; Röwert-Huber J; Ulrich M; Sterry W; Stockfleth E
    Eur J Dermatol; 2010; 20(4):482-8. PubMed ID: 20507841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical 3.0% diclofenac in 2.5% hyaluronic acid gel induces regression of cancerous transformation in actinic keratoses.
    Dirschka T; Bierhoff E; Pflugfelder A; Garbe C
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):258-63. PubMed ID: 19709346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery.
    Berlin JM; Rigel DS
    J Drugs Dermatol; 2008 Jul; 7(7):669-73. PubMed ID: 18664159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photoallergic contact dermatitis from topical diclofenac in Solaraze gel.
    Kowalzick L; Ziegler H
    Contact Dermatitis; 2006 Jun; 54(6):348-9. PubMed ID: 16787462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three percent diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses: a meta-analysis of the recent studies.
    Pirard D; Vereecken P; Mélot C; Heenen M
    Arch Dermatol Res; 2005 Nov; 297(5):185-9. PubMed ID: 16235081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory vs. inflammatory treatments for actinic keratoses.
    Ortonne JP
    J Cosmet Dermatol; 2003 Jul; 2(3-4):135-40. PubMed ID: 17163919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically determined susceptibility to COX-2 inhibitors: a report of exaggerated responders to diclofenac 3% gel in the treatment of actinic keratoses.
    Patel MJ; Ulrich C; Forschner T
    Br J Dermatol; 2007 May; 156 Suppl 3():57-61. PubMed ID: 17488409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical diclofenac: new preparation. Moderate efficacy in actinic keratosis.
    Prescrire Int; 2004 Aug; 13(72):138-9. PubMed ID: 15532138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical diclofenac 3% gel plus cryotherapy for treatment of multiple and recurrent actinic keratoses.
    Mastrolonardo M
    Clin Exp Dermatol; 2009 Jan; 34(1):33-5. PubMed ID: 18616726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reassessment of topical diclofenac/hyaluronan gel for actinic keratoses.
    Burkhart CN; Burkhart CG
    Int J Dermatol; 2002 Jun; 41(6):371-2. PubMed ID: 12100697
    [No Abstract]   [Full Text] [Related]  

  • 16. The safety of diclofenac for the management and treatment of actinic keratoses.
    Iraji F; Siadat AH; Asilian A; Enshaieh S; Shahmoradi Z
    Expert Opin Drug Saf; 2008 Mar; 7(2):167-72. PubMed ID: 18324879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of actinic cheilitis using diclofenac 3% gel: a report of six cases.
    Ulrich C; Forschner T; Ulrich M; Stockfleth E; Sterry W; Termeer C
    Br J Dermatol; 2007 May; 156 Suppl 3():43-6. PubMed ID: 17488406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp.
    Smith SR; Morhenn VB; Piacquadio DJ
    J Drugs Dermatol; 2006 Feb; 5(2):156-9. PubMed ID: 16485883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical 3% diclofenac in 2.5% hyaluronic acid gel: a review of its use in patients with actinic keratoses.
    Jarvis B; Figgitt DP
    Am J Clin Dermatol; 2003; 4(3):203-13. PubMed ID: 12627996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical therapy for actinic keratoses, II: Diclofenac, colchicine, and retinoids.
    Tutrone WD; Saini R; Caglar S; Weinberg JM; Crespo J
    Cutis; 2003 May; 71(5):373-9. PubMed ID: 12769404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.